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ABSTRACT
Objective: Oftentimes, the recombinant antigen for the use of vaccines is less immunogenic than live attenuated or inactive vaccines. Hence, a potent 
adjuvant is needed to enhance the immune response. Moreover, the role of vector design is also important to facilitate the improvement of the 
immune response. The aim of this research was to develop hepatitis B surface antigen (HBsAg)-loaded nanoparticles and Moringa oleifera aqueous 
leaf extracts as an adjuvant using chitosan polymer.
Methods: Chitosan nanoparticles were prepared by the ionic gelation method using sodium tripolyphosphate as the cross-linking agent. 
A system was composed of chitosan core in which HBsAg and M. oleifera extracts were incorporated. The concentration of HBsAg used in this 
combination was 10 µg/ml, and the concentrations of extracts were 10, 50, and 100 µg/ml, respectively. In this study, three types of nanoparticles 
were produced: HBsAg-loaded nanoparticles, M. oleifera-loaded nanoparticles, and combination of HBsAg–M. oleifera-loaded nanoparticles. 
The nanoparticles formed were characterized by the particle size, HBsAg entrapment efficiency using sodium dodecyl sulfate polyacrylamide gel 
electrophoresis, and the entrapment efficiency of extracts using the total flavonoid method.
Results: The results showed that the particle size was between 111 and 245 nm. The entrapment efficiency of HBsAg in the separate formula was 
79%, while that in the combined formula was approximately 96–98%. Furthermore, the entrapment efficiency of the extracts in the separate formula 
was around 64–91%, while that in the combined formula was 55–82.5%. Particularly, HBsAg–M. oleifera-loaded chitosan nanoparticles with the 
extract concentrations of 50 µg/ml showed the highest entrapment efficiencies of HBsAg and M. oleifera extracts of approximately 98 and 82.5%, 
respectively.
Conclusion: Collectively, the system has been successfully developed, so it is then plausible to determine the function of the devices to enhance the 
immune response in the future.
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INTRODUCTION
Hepatitis B is a type of deadly viral disease caused by the hepatitis B 
virus (HBV). Approximately 4.5 million new HBV infections occur every 
year in the world. In Indonesia, the results of basic medical research in 
2007 showed the prevalence of hepatitis B at 9.4%, which means that 
at least one in ten of the Indonesian population had been infected with 
hepatitis B or approximately 23 million people from the total population 
of Indonesia. After an acute infection, infants and adults, who become 
infected with the HBV carrier that has been carrying the disease for 
years and at a later stage, referred to the occurrence of cirrhosis and 
hepatocellular carcinoma [1].
The prevention of chronic viral hepatitis B has become a top priority 
for the global community. An approach was prepared by activating 
the appropriate immune response during chronic viral infection. 
Immunization with hepatitis B vaccine is the best preventive measure 
against infection. However, the hepatitis B vaccine can be available in 
parenteral dosage forms. It is not very effective because parenteral 
vaccines only stimulate the systemic immune response and the 
produced antibody cannot reach the mucosal surface, which is the 
main entry point of most infectious pathogens [2]. Oral vaccine delivery 
has a distinct advantage over traditional injected vaccines because it 
induces both a systemic and mucosal immune response, whereas the 
injected vaccine only leads to serum antibody production. Stimulating 
an immune response at the mucosal site is very desirable because 
many pathogens enter the body at this site. If an immune response 
occurs at the mucosal site, the pathogen can be prevented from even 
entering the body [3]. However, the vaccine administered orally has 
low bioavailability. Therefore, to boost the immune response and to 
administer oral vaccines, adjuvants and suitable delivery systems are 
required.
It has been reported that the ethanol extracts of Moringa oleifera had 
the immunostimulatory activity. Extracts of 250 mg of weight increased 
the activity of the macrophage phagocytic index by approximately 
2.85±0.81 [4]. Meanwhile, another study reported that M. oleifera 
leaves have immunomodulatory activity. The aqueous extracts of 
M. oleifera at a concentration of 0.1 mg/ml increased the number of 
cluster of differentiation 4+ (CD4+) cells and Cluster of differentiation 
8+ (CD8+) cells by approximately 54.49% and 15.57%, respectively. 
It is then believed that M. oleifera plays an important role in immune 
stimulation [5]. Recently, it was reported that M. oleifera extracts were 
loaded into gelatin nanoparticles [6]. However, there is still no report 
regarding the encapsulation of hepatitis B surface antigen (HBsAg) and 
M. oleifera extracts in nanoparticles. This research aimed to develop 
nanoparticle hepatitis B (HBsAg) vaccine using the chitosan polymer 
and to use plant-derived adjuvant for the vaccine delivery systems. 
Particularly, in the first stage, the ability of HBsAg and M. oleifera 
extracts to be packaged in the nanostructured vesicles was studied.
MATERIALS AND METHODS
Materials
M. oleifera extracts were purchased from Megasetia, Indonesia. 
Toluene, ethanol, sitroborate, sodium tripolyphosphate (STPP), acetic 
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acid, sodium hydroxide, methanol, aluminum chloride (AlCl3), acetic 
sodium, quercetin, and sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) were purchased from Sigma-Aldrich. The 
total percentage of acrylamide (T-acrylamide) 30%, Temed, and silver 
staining reagent was purchased from Thermo Fisher Scientific. HBsAg 
was kindly received from Bio Farma, Indonesia.
Methods
Examination of water content
The level of water examination was performed with the toluene distillation 
method. 200 ml of toluene was added in a distillation flask, and 7 ml of 
water was also added into the flask and heated until the toluene was 
saturated. The toluene number was recorded. 2 g of simplisia was put into 
the flask containing the saturated toluene and heated until the water was 
completely evaporated. The change in toluene numbers was recorded. In 
the examination of the water content of M. oleifera extracts, approximately 
100 mg of the extracts were weighed and analyzed by the Karl Fischer 
titrator using reagents of hydranal methanol dry and CombiTitrant.
Drying losses examination
The examination of the losses by drying was done by means of the Moisture 
Balance. Simplisia or extracts were weighed and put into the apparatus 
and heated at a temperature of 105°C. The weight of the simplisia was 
recorded before and after the examination. Then, the level of drying losses 
was then calculated.
Inspection of chromatogram pattern
The mobile phase consisted of chloroform and methanol that was 
prepared in a ratio of 9:1. 10 ml of mobile phase was put into the 
chamber and saturated. Simplisia was dissolved in ethanol followed 
by a filtration process. Quercetin was independently dissolved in 
ethanol. 10 µl of simplisia solution as well as quercetin solution was 
applied on the thin-layer chromatography (TLC) plate in the chamber 
and eluted by the mobile phase. The TLC plate was dried and sprayed 
with Borocitric solution, followed by heating at 100°C for 2 min. Spots 
of chromatogram pattern were detected under ultraviolet (UV) light 
at a wavelength of 366 nm. To check the chromatogram pattern of 
M. oleifera extracts, the procedure was similar to that of simplisia as 
described above, except that the ratio of mobile phase of chloroform to 
methanol was approximately 8:2.
Determination of total flavonoid content
About 50 mg of simplisia was dissolved in methanol to obtain a 
concentration of 5000 µg/ml and then filtered to remove the remaining 
undissolved simplisia. 0.5 ml of this solution was added with 1.5 ml of 
methanol, 0.1 ml of 10% AlCl3, and 0.1 ml of 1 M sodium acetate and then 
incubated in a dark room for 30 min. The sample was then analyzed by 
an UV-visible spectrophotometer at a maximum wavelength of 432 nm.
Preparation of chitosan nanoparticles carrying HBsAg and 
M. oleifera extracts
Chitosan was dissolved in 1% acetic acid (v/v) to form a concentration of 
1.4 mg/ml with a pH of 5. STPP was dissolved in distilled water to form 
a concentration of 1.47 mg/ml. HBsAg concentration of 10 µg/ml along 
with extract concentrations of 10, 50, and 100 µg/mL was incubated with 
a chitosan solution of pH 5 for 30 min. Nanoparticles were spontaneously 
formed through the ionotropic gelation process. Technically, 250 µl of 
the STPP solution was added dropwise to a 750 µl of chitosan solution 
containing HBsAg and extracts using a 1 ml syringe. It was then stirred 
at room temperature using a magnetic stirrer. The suspension was 
centrifuged at 13,000 rpm for 10 min, and the supernatant was collected 
to determine the entrapment efficiencies of HBsAg and the extracts. The 
precipitates were redispersed in 100 µl of deionized water and sonicated at 
60 Hz for 10 s. Then, the final nanoparticles suspension was characterized.
Characterization of particle size and polydispersity index
Particle size analysis was performed using DelsaTM NanoC (Beckman 
Coulter). The instrument can measure particle sizes in the range of 
0.6 nm–7 µm, with an optimum concentration of 0.001%–40%.
Determination of the entrapment efficiency of HBsAg
The entrapment efficiency was determined through an indirect method 
by measuring the amount of free HBsAg that was unencapsulated in 
the nanoparticles. The HBsAg assay was done using silver staining on 
SDS-PAGE gel with the silver PROTEO kit and observed by a densitometer. 
The concentration of SDS gel used was 12%. The SDS gel was prepared 
in two stages, separating the gel preparation and the stacking gel. After 
the gel was formed, the sample supernatant was mixed with a sample 
buffer (2:1) and then denatured using a thermomixer (temperature 
95°C, 300 rpm, 5 min). It was then added to the SDS gel through the 
wall of the stacking gel and run for 80 min at a power of 120 V. Silver 
staining was performed using a silver PROTEO kit, including fixation, 
sensitization, silver equilibrium, development, and stopping reaction 
in an incubator shaker (20°C, 60 rpm). The gels were scanned using 
a densitometer and analyzed using Image-J program to determine the 
efficiency of the entrapment.
Determination of entrapment efficiency of M. oleifera extracts
The entrapment efficiency of the extracts was also determined 
through an indirect method by measuring the amount of extract that 
was unencapsulated in the nanoparticles. We tracked quercetin in the 
free extracts as a marker through total flavonoid method to reflect the 
amount of free extracts. The supernatant was separated, and 0.5 ml 
of supernatant was added with 1.5 ml of methanol, 0.1 ml of 10% 
AlCl3, 0.1 ml of 1 M sodium acetate, and distilled water. Due to the low 
absorbance of the samples, we utilized the addition method in the test 
by adding known concentrations of quercetin. The concentrations of 
quercetin were 5, 7.5, and 10 μg/ml, respectively. The samples were 
incubated in the dark room for 30 min and analyzed with a UV-Vis 
spectrophotometer at a maximum wavelength of 432 nm.
RESULTS AND DISCUSSION
This study presented the packaging of HBsAg and M. oleifera into 
nanoparticles in which the chitosan polymer was used. It has recently 
been demonstrated that silver nanoparticles (AgNPs) were synthesized 
from the leaf extracts of M. oleifera [7]. However, the toxicity of 
particularly AgNPs to various organisms, such as Pseudomonas putida, 
Escherichia coli, Daphnia magna, and Chlamydomonas reinhardtii, 
is undeniable [7]. It has also been suggested that the three major 
mechanisms of AgNPs toxicity appear to directly damage cell 
membranes, generate reactive oxygen species, and release Ag ions [8]. 
Therefore, in this study, we focused on the use of biodegradable 
polymers such as chitosan to encapsulate HBsAg and M. oleifera 
extracts, whose degradation polymers cannot be harmful and ensure 
removal from the body.
Characterization of simplisia and extracts of M. oleifera
This study aimed to investigate the ability of nanoparticles to encapsulate 
HBsAg and M. oleifera extracts in the same structure to accommodate 
HBsAg vaccine for enhancing its immune response. Previously, we 
examined the standardization of M. oleifera simplisia according to the 
requirements of the Indonesian Herbal Pharmacopoeia. As a result, 
the simplisia have met the requirements based on test parameters 
and microscopic studies, and thus, it can be extracted for its use as an 
adjuvant (Table 1).
In the case of the standardization of M. oleifera extracts, it was based 
on a chromatogram pattern of the ethanol extracts of its leaves. On the 
basis of the results of the chromatogram pattern, it is likely that the 
pattern of the extracts is similar to that of simplisia (Fig. 1). The results 
Table 1: Simplisia Characteristic Data
Test parameters Results (%) Requirements
Drying losses 7.06±0.0 4 Not >12%
Water content 5.25±0.35 Not >10%
Total flavonoid level 1.42±0.06 Not <0.5%
Values represent mean±SD, n=3
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indicate that the extraction method is suitable to ensure the quality 
under the requirements. In addition, other examination parameters 
of the aqueous extracts of M. oleifera were performed as a quality 
control of the extracts. The results of yield, drying losses, and water 
content of the extracts were 17.44%, 9.79±0.23%, and 8.24±0.82%, 
respectively. The results of the drying losses and water content of the 
aqueous extracts also meet the requirements of the Indonesian Herbal 
Pharmacopoeia.
The total flavonoid content test result was 0.77±0.03%. Our data 
were comparable with previous data, showing that the total flavonoid 
level of aqueous extracts of M. oleifera leaves was 0.95±0.07% [9]. 
The determination of total flavonoid levels is one of the important 
parameters since flavonoids such as kaempferol, rhamnetin, 
isoquercetin, and kaempferitrin are natural immunomodulators that 
play a role in increasing the immune response [10,11]. M. oleifera 
leaves are also known to be rich in quercetin, glycosides, kaempferol, 
and saponin if we compare with another part of the plant, such as the 
bark. It also has been used in the Ayurveda and Unani medicine system 
for a long time [12,13]. In general, the standardized parameters of 
the extracts fulfilled the pharmacopeia requirements and the extracts 
were allowed to be investigated for packaging into the nanostructured 
particles.
Preparation of chitosan nanoparticles
The preparation of chitosan nanoparticles as an antigen carrier matrix 
was performed using the ionotropic gelation method. It is based on the 
interaction between the positive charge of the protonated NH2 moiety 
of chitosan in an acid solution that forms NH3+ and a negative charge 
of the polyanion STPP as a cross-linker [14]. We characterized the 
nanoparticles in terms of particle size and polydispersity index. The 
produced chitosan nanoparticles had a size in the range of 111–245 nm 
(Table 2). When the empty nanoparticles were incorporated by HBsAg, 
the size of the nanoparticles increased significantly. Moreover, when 
M.  oleifera extracts were loaded into the nanoparticles, the particle size 
was even larger. These results indicate that the size of HBsAg is smaller 
than that of M. oleifera extracts. It is well known that the size of HBsAg 
was merely 20–33 nm [15]. Thus, our data are in line with the fact of the 
HBsAg size in which the empty nanoparticles had a size of 111 nm and 
the particles were enhanced by approximately 144 nm when HBsAg 
was loaded into the particles.
Moreover, the combination of HBsAg and M. oleifera extracts loaded with 
chitosan nanoparticles was smaller in size than the extracts of merely 
M. oleifera encapsulated in the particles. Presumably, the extracts 
have a low molecular weight and a single dimension of conformation 
compared to the virus-like particle (VLP) of HBsAg. When HBsAg was 
encapsulated into the chitosan nanoparticles along with the M. oleifera 
extracts, it is likely that the extracts enter the inner space of the HBsAg 
VLP and also interacts with chitosan through covalent bonding resulting 
in a smaller particle size [16]. Based on the previous study, the low 
molecular weight of memantine hydrochloride-loaded nanoparticle 
had a particle size of around 203 nm in an STPP and chitosan ratio of 
approximately 1:3 [17]. In line with our study using a similar system, 
the results emphasized on the efficiency of the encapsulation since 
the particles were comparable in size with the previous report, even 
though we packaged a combination of low molecular weight of HBsAg 
and high molecular weight of M. oleifera extract compounds in the same 
vesicle. This was due to the formation of nanoparticles that depend on 
the stirring speed and intermolecular cross-linking between STPP and 
chitosan in the preparation of nanoparticles [18-20]. In this study, we 
used a stirring rate at 800 rpm, which was lower than the previously 
reported 1000 rpm [17]. It was clearly shown that the particle size 
distribution was significantly narrowed by increasing the stirring rate 
from 200 to 800 rpm. Furthermore, the increase in the stirring rate at 
1000 rpm leads to an aggregate formation [18]. It is hypothesized that an 
adequate stirring rate accelerates the dispersion of STPP in the chitosan 
solution and the increase in shear forces improves the monodispersity, 
while an intense stirring rate may destroy the repulsive force between 
the particles and lead to aggregation of the particles.
In addition, we added STPP dropwise to the chitosan solution in the 
preparation of nanoparticles. This method prevented intermolecular 
crosslinking that leads to a larger particle size. It has been explained 
that the formation of aggregates leading to the formation of larger 
particles depends on the contact time between the particles when 
they collide [19,20]. Time is also essential to obtain a permanent chain 
entanglement between the particles when they spontaneously crosslink 
to form a microgel through the interaction between the positive charge 
of chitosan and the negative charge of STPP [19,20]. Therefore, it is 
likely that the role of stirring rate and STPP addition technique is 
important in this study to package HBsAg and M. oleifera extracts.
Particle size plays an important role in the nanoparticle delivery system. 
Magnocellular cells (M cells) in the follicle-associated epithelium 
intestinal Peyer’s patches are oral vaccine delivery targets, and hence, 
the formula should facilitate that the preparations are absorbed by the 
M cells. If the particle size is <1 µm, it is internalized and systemically 
transported to the M cells, which potentially generates a systemic 
immune response. As for the large-sized particles, they will remain in 
the intestinal epithelium for an immune response to appear as a local 
immune response [21]. Based on the results of the particle size in 
Table 2, it seems that the particle size has a potential to be internalized 
in the M cells to provide a systemic immune response.
The particle size distribution is expressed as a polydispersity index. 
The results obtained from the polydispersity index study ranged 
from 0.05 to 0.39. The results reveal that the produced nanoparticles 
have reasonably good physical stability. The acceptable value of the 
Table 2: Characteristics of nanoparticles




1. Empty nanoparticles 111.1±8.5 0.051–0.277
2. Nano-HBsAg 10 µg/ml 143.8±18.7 0.172–0.346
3. Nano-M. oleifera 10 µg/ml 221.9±13.1 0.251 – 0.277
4. Nano-M. oleifera 50 µg/ml 239.7±25.9 0.160–0.392
5. Nano-M. oleifera 100 µg/ml 244.6±49.1 0.052–0.278
6. Nano-HBsAg+M. oleifera 10 µg/ml 181.8±33.1 0.173–0.356
7. Nano-HBsAg+M. oleifera 50 µg/ml 219.8±50.5 0.195–0.327
8. Nano-HBsAg+M. oleifera 100 µg/ml 219.2±52.4 0.182–0.224
Values of particle size represent mean±SD, n=3 and data of polydispersity 
index represents range, M. oleifera: Moringa oleifera, HbsAg: Hepatitis B surface 
antigen
Fig. 1: Chromatogram pattern of (a) simplisia with Rf 0.27 and 
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polydispersity index is from 0 (monodisperse particles) to 0.5 (wide 
particle size distribution). The low polydispersity index indicates that 
the formed dispersion system is more stable in the long term [22].
Entrapment efficiency of HBsAg
The entrapment efficiency of HBsAg was determined using an indirect 
method by measuring HBsAg unencapsulated in the nanoparticles. It 
was examined using silver staining on SDS-PAGE. In this method, the 
gel was stained with silver dye and scanned with a densitometer to 
capture the density in the image. As a result, nanoparticles containing 
a combination of HBsAg and M. oleifera extracts with the same 
concentration of 10 µg ml provided the highest entrapment efficiency 
of approximately 98.59% (Table 3). The lowest one was given by the 
10 µg ml HBsAg nanoparticles. It is possible that the small size of 
the HBsAg-loaded nanoparticles of approximately 144 nm limits the 
entrapment of HBsAg, where it shapes VLP with a size of 20–33 nm. 
In addition, the results of the captured image from SDS-PAGE showed 
that there was a slight monomer band that appeared in the supernatant 
samples (Fig. 2, lanes 3–6). Those were having sizes of 26 kDa, which 
have the same size as HBsAg standard marker. Thus, it is likely that 
it reflected a minor unencapsulated HBsAg. Since the encapsulation 
efficiency of HBsAg was high of a minimum of 96%, the packaging of 
HBsAg was considered successful. In nanoparticles encapsulating the 
combination w HBsAg and M. oleifera extracts, the entrapment efficiency 
of HBsAg was concomitant with an increase in the concentration of 
the extracts. This suggests that there is a possibility of competition 
between the HBsAg and the extracts to be located in the chitosan-based 
nanoparticles.
ENTRAPMENT EFFICIENCY OF M. OLEIFERA EXTRACTS
The aqueous extract of M. oleifera was highly entrapped in the 
chitosan-based nanoparticles in a range of 64–91%. It seemed 
that the highest entrapment efficiency of 91% was provided by 
the use of the concentration of M. oleifera extracts of 50 µg/ml. 
Furthermore, in the case of the entrapment efficiency of M. oleifera 
extracts in the nanoparticles loaded with a combination of HBsAg 
and the extracts, it showed a high level of approximately a range 
of 55–82.5%. The highest entrapment efficiency was also obtained 
using the concentration of extracts of 50 µg/ml. Thus, the maximum 
entrapment capacity of the extracts having a concentration of 50 µg/
ml was shown. Basically, the competition between HBsAg and M. 
oleifera extracts occurs in the nanoparticles so that, particularly 
in the case of combination, the entrapment efficiency was lower 
than that of a single compound. Our results show that the high 
entrapment efficiency of M. oleifera extracts is 91%, which is better 
than previous studies. It was reported that the gelatin nanoparticles 
encapsulated with M. oleifera extracts had an entrapment efficiency 
of around 83% [5]. Meanwhile, our results showed a comparable 
entrapment efficiency of M. oleifera of approximately 82.5%, and 
especially, it is in combination with HBsAg, which also showed a high 
entrapment efficiency of 98%. To the best of our knowledge, this is 
the first report of packaging two compounds of HBsAg vaccine and 
M. oleifera extracts in the same nanostructure. The potential function 
of the produced chitosan-based nanoparticles loaded with HBsAg-M. 
oleifera extracts in enhancing the immune response of HBsAg needs 
to be clarified in the future.
CONCLUSION
The results of the present study concluded that the HBsAg vaccine along 
with the aqueous extracts of M. oleifera was successfully packaged in 
the chitosan-based nanostructured particles with highly entrapment 
efficiencies of HBsAg and M. oleifera extracts.
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